title: Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.
authors.affiliation: a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
authors.forename: Mark-Alexander
authors.initials: MA
authors.lastname: Schwarzbich
authors.affiliation: b Department of Pharmacy , University Hospital Heidelberg , Heidelberg , Germany.
authors.forename: Tilman
authors.initials: T
authors.lastname: Schöning
authors.affiliation: a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
authors.forename: Martin
authors.initials: M
authors.lastname: Cremer
authors.affiliation: a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
authors.forename: Katharina
authors.initials: K
authors.lastname: Lisenko
authors.affiliation: a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Ho
authors.affiliation: a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
authors.forename: Matthias
authors.initials: M
authors.lastname: Witzens-Harig
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D018572:Disease-Free Survival; D064147:Febrile Neutropenia / Q000139:chemically induced; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced; D012189:Retrospective Studies; D012307:Risk Factors; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000069283:Rituximab; D008727:Methotrexate